Heterogeneity of osteogenesis imperfecta

Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome.

Frontiers in genetics·2023

Electron microscopy in the diagnosis of Ehlers-Danlos syndromes: correlation with clinical and genetic investigations.

The British journal of dermatology·2019

Two patients with Ehlers-Danlos syndrome type VIII with unexpected hoarseness.

Clinical and experimental dermatology·2016

Palmoplantar contractures in childhood: a rare complication of vascular Ehlers-Danlos syndrome.

Clinical and experimental dermatology·2013

An atypical cutaneous presentation of vasculitis with features of Churg-Strauss syndrome, associated with anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies.

Clinical and experimental dermatology·2009

A glycine to aspartic acid substitution of COL2A1 in a family with the Strudwick variant of spondyloepimetaphyseal dysplasia.

QJM : monthly journal of the Association of Physicians·2003

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Negative linear compressibility of a one-dimensional interpenetrated metal-organic framework.

Chemical science·2026

Electronic and steric control of phase changes caused by methylamine insertion into copper paddlewheel metal-organic frameworks.

Chemical science·2026

Ligand isomerism in coordination cages: to interlock or not to interlock.

Chemical science·2026

A C-H activation-based multicomponent reaction approach towards benzimidazole-linked covalent organic frameworks for proton conduction.

Chemical science·2026

Framework-Controlled Axial Coordination of Guest Molecules in Metalloporphyrin-Based MOFs.

Inorganic chemistry·2026

Regioselective heteroatom embedded ullazine framework: synthesis, structure-property relationships, and applications in organic electronics.

Chemical communications (Cambridge, England)·2026

Related Experiment Videos

Heterogeneity of osteogenesis imperfecta

Related Concept Videos

Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome.

Electron microscopy in the diagnosis of Ehlers-Danlos syndromes: correlation with clinical and genetic investigations.

Two patients with Ehlers-Danlos syndrome type VIII with unexpected hoarseness.

Palmoplantar contractures in childhood: a rare complication of vascular Ehlers-Danlos syndrome.

An atypical cutaneous presentation of vasculitis with features of Churg-Strauss syndrome, associated with anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies.

A glycine to aspartic acid substitution of COL2A1 in a family with the Strudwick variant of spondyloepimetaphyseal dysplasia.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Negative linear compressibility of a one-dimensional interpenetrated metal-organic framework.

Electronic and steric control of phase changes caused by methylamine insertion into copper paddlewheel metal-organic frameworks.

Ligand isomerism in coordination cages: to interlock or not to interlock.

A C-H activation-based multicomponent reaction approach towards benzimidazole-linked covalent organic frameworks for proton conduction.

Framework-Controlled Axial Coordination of Guest Molecules in Metalloporphyrin-Based MOFs.

Regioselective heteroatom embedded ullazine framework: synthesis, structure-property relationships, and applications in organic electronics.

Related Experiment Videos

Heterogeneity of osteogenesis imperfecta

Related Concept Videos

Related Articles